T-DM1 vs Paclitaxel/Trastuzumab for Breast (ATEMPT Trial)
Clinical trial NCT01853748 · COMPLETED
Trial details
- NCT number
- NCT01853748
- Sponsor
- Dana-Farber Cancer Institute
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2013-05-01
- Primary completion
- 2019-08-26
- Enrollment
- 512
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.